Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oral Intestinal Microbiota Capsule
- Development stage
- Unknown
- Lead developer
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
The Oral Intestinal Microbiota Capsule is a live biotherapeutic product developed by the Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran. It consists of frozen intestinal microbiota harvested from healthy donors and is encapsulated for oral administration. The therapy is designed to restore the natural diversity and ecological balance of the gut microbiome in patients whose commensal flora has been disrupted, particularly those undergoing prolonged antibiotic therapy. By re-establishing a healthy microbial environment, the capsules aim to achieve the decolonization of multidrug-resistant organisms (MDROs) and Clostridioides difficile through competitive exclusion and other ecological mechanisms. It is currently being evaluated in Phase 1/2 clinical trials for safety and efficacy in hospitalized adult patients.
- Other names
- Microbiota capsuleOral intestinal microbiotaFecal microbiota transplantation capsuleFMT capsule
Beyond the preview
Go deeper on Oral Intestinal Microbiota Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oral Intestinal Microbiota Capsule.